Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
394 High-affinity PRAME TCRs synergize with tailored CD8 co-receptor and switch receptors to generate potential best-in-class PRAME-targeting TCR-T therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
